Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Feb, 23 2026
Feb, 7 2026
Aug, 21 2025
May, 14 2026
Feb, 2 2026